155 related articles for article (PubMed ID: 1968250)
1. Amperozide--a new putatively antipsychotic drug with a limbic mode of action on dopamine mediated behaviour.
Gustafsson B; Christensson E
Pharmacol Toxicol; 1990; 66 Suppl 1():12-7. PubMed ID: 1968250
[TBL] [Abstract][Full Text] [Related]
2. Behavioral and biochemical effects of amperozide and serotonin agents on nigrostriatal and mesolimbic dopamine systems.
Chang PY; Chuang CH; Chen JC; Tung CS
Chin J Physiol; 2008 Apr; 51(2):106-15. PubMed ID: 18666714
[TBL] [Abstract][Full Text] [Related]
3. The effect of amperozide on uptake and release of [3H]-dopamine in vitro from perfused rat striatal and limbic brain areas.
Eriksson E; Christensson E
Pharmacol Toxicol; 1990; 66 Suppl 1():45-8. PubMed ID: 2304895
[TBL] [Abstract][Full Text] [Related]
4. The putatively antipsychotic agent amperozide produces behavioural stimulation in the rat. A behavioural and biochemical characterization.
Waters N; Pettersson G; Carlsson A; Svensson K
Naunyn Schmiedebergs Arch Pharmacol; 1989 Aug; 340(2):161-9. PubMed ID: 2572972
[TBL] [Abstract][Full Text] [Related]
5. Amperozide and emotional behaviour.
Gustafsson B; Christensson E
Pharmacol Toxicol; 1990; 66 Suppl 1():34-9. PubMed ID: 2304894
[TBL] [Abstract][Full Text] [Related]
6. Amperozide and conditioned behaviour in rats: potentiation by classical neuroleptics and alpha-methylparatyrosine.
Egbe P; Engel J; Gustafsson B; Christensson E
Pharmacol Toxicol; 1990; 66 Suppl 1():18-21. PubMed ID: 1968251
[TBL] [Abstract][Full Text] [Related]
7. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
[TBL] [Abstract][Full Text] [Related]
8. Effects of amperozide on induced turning behaviour in 6-OHDA lesioned rats.
Christensson EG
Pharmacol Toxicol; 1990; 66 Suppl 1():22-8. PubMed ID: 2106130
[TBL] [Abstract][Full Text] [Related]
9. The limbic functional selectivity of amperozide is not mediated by dopamine D2 receptors as assessed by in vitro and in vivo binding.
Svartengren J; Celander M
Eur J Pharmacol; 1994 Mar; 254(1-2):73-81. PubMed ID: 7911431
[TBL] [Abstract][Full Text] [Related]
10. Neuroleptic activity of 10-(4-methyl-1-piperazinyl)-thieno[3,2-b] [1,5]benzoxazepine and benzothiazepine derivatives.
Corral C; Lissavetzky J; Valdeolmillos A; Bravo L; Darias V; Sánchez Mateo C
Arzneimittelforschung; 1992 Jul; 42(7):896-900. PubMed ID: 1358080
[TBL] [Abstract][Full Text] [Related]
11. A rapid and simple behavioural screening method for simultaneous assessment of limbic and striatal blocking effects of neuroleptic drugs.
Ljungberg T; Ungerstedt U
Pharmacol Biochem Behav; 1985 Sep; 23(3):479-85. PubMed ID: 2864704
[TBL] [Abstract][Full Text] [Related]
12. Locomotor effects of amperozide. Antagonism of amphetamine-induced locomotor stimulation.
Egbe PC
Arzneimittelforschung; 1989 Oct; 39(10):1223-4. PubMed ID: 2514690
[TBL] [Abstract][Full Text] [Related]
13. Effects of amperozide and tiospirone, atypical antipsychotic 5-HT2 drugs, on food-reinforced behavior in rats.
Arolfo MP; McMillen BA
Physiol Behav; 1999 Dec 1-15; 68(1-2):93-8. PubMed ID: 10627067
[TBL] [Abstract][Full Text] [Related]
14. The effect of the atypical antipsychotic drug, amperozide, on carrier-mediated striatal dopamine release measured in vivo.
Yamamoto BK; Meltzer HY
J Pharmacol Exp Ther; 1992 Oct; 263(1):180-5. PubMed ID: 1403783
[TBL] [Abstract][Full Text] [Related]
15. [Antipsychotic drug modification of motor hyperactivity and stereotyped behavior induced by amphetamine in rats with lesions in the nigrostriatal and mesolymbic dopaminergic systems].
Sánchez-Blázquez P; Fernández-Tomé MP; Fuentes JA; del Río J
Arch Farmacol Toxicol; 1978 Apr; 4(1):66-8. PubMed ID: 29574
[No Abstract] [Full Text] [Related]
16. Effect of amperozide on rat cortical 5-HT2 and striatal and limbic dopamine D2 receptor occupancy: implications for antipsychotic action.
Meltzer HY; Zhang Y; Stockmeier CA
Eur J Pharmacol; 1992 May; 216(1):67-71. PubMed ID: 1388121
[TBL] [Abstract][Full Text] [Related]
17. Effects of amperozide, a putative antipsychotic drug, on rat midbrain dopamine neurons recorded in vivo.
Grenhoff J; Tung CS; Ugedo L; Svensson TH
Pharmacol Toxicol; 1990; 66 Suppl 1():29-33. PubMed ID: 2304893
[TBL] [Abstract][Full Text] [Related]
18. Amperozide, a novel antipsychotic drug, inhibits the ability of d-amphetamine to increase dopamine release in vivo in rat striatum and nucleus accumbens.
Ichikawa J; Meltzer HY
J Neurochem; 1992 Jun; 58(6):2285-91. PubMed ID: 1349347
[TBL] [Abstract][Full Text] [Related]
19. A critical assessment of behavioural test procedures used to analyse dopaminergic and antidopaminergic drugs.
Nohria V
Methods Find Exp Clin Pharmacol; 1983; 5(6):357-64. PubMed ID: 6137599
[No Abstract] [Full Text] [Related]
20. Amperozide--effect on prolactin release in the rat.
Albinsson A; Eriksson E; Andersson G
Pharmacol Toxicol; 1990; 66 Suppl 1():49-51. PubMed ID: 2304896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
